Roadrunner Capitol Reports
Legislation Detail

HB 149 MEDICATION FOR JUVENILES IN TREATMENT PGMS.

Rep Cristina Parajon

Actions: [2] HHHC/HAFC-HHHC [5] DP-HAFC

Scheduled: Not Scheduled

image of sponsor
Summary:
 House Bill 149 (HB 149) This legislation in the state of New Mexico focuses on medication-assisted treatment for minors with substance use disorder and establishes a fund to support these programs. 
Legislation Overview:
 House Bill 149 (HB 149) Section 1 - "Evidence-based" refers to a treatment supported by research, clinical expertise, and patient needs.
•	"Inpatient substance abuse treatment facility" is a residential facility providing intensive addiction management.
•	“Medication-assisted treatment" involves FDA-approved drugs for substance use disorder.
•	"Minor" refers to an individual under eighteen. 
•	"Outpatient substance abuse treatment program" offers resources and counseling on an outpatient basis.
Section 2: By the end of fiscal year 2025, state health and family departments should not operate or contract with facilities limiting medication-assisted treatment for minor patients.
•	From July 1, 2026, such facilities won't be eligible for Medicaid reimbursement for services to minors. 
•	Rules for medication-assisted treatment programs in these facilities will be established by December 1, 2024. 
•	The Health Care Authority Department will report annually from October 1, 2024, on the availability of medication-assisted treatment for minors.
Section 3: Evidence-Based Addiction Treatment for Minors Fund:
•	The fund is created in the state treasury for evidence-based addiction treatment. 
•	It includes appropriations, gifts, grants, and donations. 
•	Administered by the Health Care Authority Department, funds assist in establishing and operating medication-assisted treatment programs for minors. 
•	Disbursements are made by warrants of the secretary of finance and administration.
By December 1, 2024, the Health Care Authority Department will establish rules for fund disbursement, including eligibility criteria.